中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
14期
913-916
,共4页
孙建娜%骆瑞珍%孔令军%高峰%许华%宋红雨%黄梅
孫建娜%駱瑞珍%孔令軍%高峰%許華%宋紅雨%黃梅
손건나%락서진%공령군%고봉%허화%송홍우%황매
自动乳腺全容积成像%彩色多普勒超声%乳腺癌%新辅助化疗%疗效评价
自動乳腺全容積成像%綵色多普勒超聲%乳腺癌%新輔助化療%療效評價
자동유선전용적성상%채색다보륵초성%유선암%신보조화료%료효평개
ABVS%CDFI%breast cancer%neoadjuvant chemotherapy%therapeutic evaluation
目的:探讨自动乳腺全容积成像(ABVS)与彩色多普勒超声(CDFI)对乳腺癌新辅助化疗(NCT)疗效评价的意义。方法:应用ABVS与CDFI对42例乳癌患者NCT前后的病灶成像特点进行观察与分析。结果:42例乳癌患者接受NCT后,其中完全缓解的患者ABVS从冠状面显示原发肿瘤分布范围及声像改变,CDFI图像显示原发灶内血流变化等均具有显著性差异(P<0.01);而在无变化及部分缓解的病灶中的ABVS从冠状面显示原发肿瘤分布范围及声像改变,CDFI显示病灶内血流变化等均无显著性差异(P>0.05)。结论:利用ABVS与CDFI对乳癌NCT前后疗效评价具有较大的临床意义及价值。
目的:探討自動乳腺全容積成像(ABVS)與綵色多普勒超聲(CDFI)對乳腺癌新輔助化療(NCT)療效評價的意義。方法:應用ABVS與CDFI對42例乳癌患者NCT前後的病竈成像特點進行觀察與分析。結果:42例乳癌患者接受NCT後,其中完全緩解的患者ABVS從冠狀麵顯示原髮腫瘤分佈範圍及聲像改變,CDFI圖像顯示原髮竈內血流變化等均具有顯著性差異(P<0.01);而在無變化及部分緩解的病竈中的ABVS從冠狀麵顯示原髮腫瘤分佈範圍及聲像改變,CDFI顯示病竈內血流變化等均無顯著性差異(P>0.05)。結論:利用ABVS與CDFI對乳癌NCT前後療效評價具有較大的臨床意義及價值。
목적:탐토자동유선전용적성상(ABVS)여채색다보륵초성(CDFI)대유선암신보조화료(NCT)료효평개적의의。방법:응용ABVS여CDFI대42례유암환자NCT전후적병조성상특점진행관찰여분석。결과:42례유암환자접수NCT후,기중완전완해적환자ABVS종관상면현시원발종류분포범위급성상개변,CDFI도상현시원발조내혈류변화등균구유현저성차이(P<0.01);이재무변화급부분완해적병조중적ABVS종관상면현시원발종류분포범위급성상개변,CDFI현시병조내혈류변화등균무현저성차이(P>0.05)。결론:이용ABVS여CDFI대유암NCT전후료효평개구유교대적림상의의급개치。
Objective: To explore automatic breast full volume imaging (ABVS) and color doppler ultrasound (CDFI) for breast cancer neoadjuvant chemotherapy (NCT) in the evaluation of curative effect. Methods:The application of a CDFI and ABVS 42 cases of breast cancer patients receiving NCT lesions imaging characteristics before and after observation and analysis. Results:ABVS from coronal distribution and audio-visual change according to the primary tumor, and CDFI images showing the primary tumors and blood flow changes within all have significant difference in patients with complete remission after NCT (P<0.01);ABVS from coronal distri-bution and audio-visual change according to the primary tumor, and CDFI showed lesions in blood flow changes, etc. in patients with the absence of change and easing some lesions have no significant difference (P>0.05). Conclusion:We use ABVS and CDFI for breast cancer before and after the NCT curative effect evaluation of great clinical significance and value.